Cargando…

Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study

BACKGROUND: Kidney transplantation is the optimal treatment in end stage renal disease but the allograft survival is still hampered by immune reactions against the allograft. This process is driven by the recognition of allogenic antigens presented to T-cells and their unique T-cell receptor (TCR) v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aschauer, Constantin, Jelencsics, Kira, Hu, Karin, Heinzel, Andreas, Vetter, Julia, Fraunhofer, Thomas, Schaller, Susanne, Winkler, Stephan, Pimenov, Lisabeth, Gualdoni, Guido A., Eder, Michael, Kainz, Alexander, Regele, Heinz, Reindl-Schwaighofer, Roman, Oberbauer, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719356/ https://www.ncbi.nlm.nih.gov/pubmed/31477052 http://dx.doi.org/10.1186/s12882-019-1541-5

Ejemplares similares

Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
por: Aschauer, Constantin, et al.
Publicado: (2021)

ImmunoDataAnalyzer: a bioinformatics pipeline for processing barcoded and UMI tagged immunological NGS data
por: Vetter, Julia, et al.
Publicado: (2022)

Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant Recipients
por: Aschauer, Constantin, et al.
Publicado: (2022)

Steroid pretreatment of organ donors does not impact on early rejection and long‐term kidney allograft survival: Results from a multicenter randomized, controlled trial
por: Reindl‐Schwaighofer, Roman, et al.
Publicado: (2019)

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Novel insights into non‐HLA alloimmunity in kidney transplantation
por: Reindl‐Schwaighofer, Roman, et al.
Publicado: (2019)

Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 Vaccines
por: Aschauer, Constantin, et al.
Publicado: (2023)

Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in Blood
por: Weinberger, Johannes, et al.
Publicado: (2015)

Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2017)

Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial
por: Doberer, Konstantin, et al.
Publicado: (2021)

Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
por: Borski, Anita, et al.
Publicado: (2022)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
por: Regele, Florina, et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
por: Stiasny, Karin, et al.
Publicado: (2022)

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis
por: Aschauer, Constantin, et al.
Publicado: (2017)

Imaging alloreactive T cells provides early warning of organ transplant rejection
por: Hirai, Toshihito, et al.
Publicado: (2021)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejection
por: Barbetta, Arianna, et al.
Publicado: (2023)

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients
por: Strassl, Robert, et al.
Publicado: (2019)

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2021)

Defining the Alloreactive T Cell Repertoire Using High-Throughput Sequencing of Mixed Lymphocyte Reaction Culture
por: Emerson, Ryan O., et al.
Publicado: (2014)

High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity
por: Fu, Jianing, et al.
Publicado: (2021)

Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy
por: Dunlap, Garrett S., et al.
Publicado: (2023)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune Response
por: Bettens, Florence, et al.
Publicado: (2021)

Predicting Alloreactivity in Transplantation
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

COVID-19 und Nierentransplantation
por: Regele, Florina, et al.
Publicado: (2021)

The Cholinergic Anti-Inflammatory Pathway Delays TLR-Induced Skin Allograft Rejection in Mice: Cholinergic Pathway Modulates Alloreactivity
por: Sadis, Claude, et al.
Publicado: (2013)

Skin and heart allograft rejection solely by long-lived alloreactive T(RM) cells in skin of severe combined immunodeficient mice
por: Tian, Qianchuan, et al.
Publicado: (2022)

Alloreactivity-Based Medical Conditions
por: Vukmanovic, Stanislav, et al.
Publicado: (2013)

Metabolic Pathways in Alloreactive T Cells
por: Brown, Rebecca A., et al.
Publicado: (2020)

Perturbations of the T-cell immune repertoire in kidney transplant rejection
por: Sigdel, Tara K., et al.
Publicado: (2022)

CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model
por: ZHUANG, JIAWEI, et al.
Publicado: (2014)

Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)
por: Dörr, Katharina, et al.
Publicado: (2019)

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
por: Dörr, Katharina, et al.
Publicado: (2022)

On the nature of peptides involved in T cell alloreactivity
Publicado: (1991)

Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection
por: Alachkar, Houda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1q5i956cv6c31e0dvlffrg4kpa